Bocouture 50iu Vial (Twin Pack)

£135.00

(Prices are subject to change on a daily basis)

Rx With prescription purchase

To place an order please Sign In or Register.

Bocouture is a prescription-only medicine indicated for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows. Suitable for the treatment of glabellar frown lines, periorbital lines crow’s feet lines and horizontal forehead lines in adult patients under 65 years.

RxWith prescription purchase
Category:

BOCOUTURE is a prescription-only medicine that contains the active substance Botulinum toxin type A which relaxes the injected muscles. It is used for temporary improvement of upper facial lines in adults under 65 years of age.

Bocouture helps to relax muscles, by initially blocking the nerve impulses. Bocouture is injected into the muscle area to relax muscles by preventing the constant contraction of them. This effect is reversible and temporary and requires further treatments to maintain its longevity, making it a safe option for patients who choose this medicine.

Treatment Areas:
Vertical Lines between the Eyebrows seen at maximum frown (Glabellar Frown Lines)
Lateral Periorbital Lines seen at maximum smile (Crow’s feet lines)
Horizontal Forehead Lines seen at maximum contraction

When will results first start to be visible?
Improvement is observed between 2-3 days, however full effects can be seen on day 30.

How long will the result last?
Effects can last for up to 4 months following treatment, hence Bocouture being a temporary reversible solution for many patients.

Contraindications of Bocouture:
Hypersensitivity to the active substance or to any of the excipients.
Generalised disorders of muscle activity (e.g. myasthenia gravis, Lambert- Eaton syndrome).
Infection or inflammation at the proposed injection site.

Who should not use Bocouture?
The injection of Bocouture is not recommended for patients with a history of aspiration or dysphagia.
Patients suffering from amyotrophic lateral sclerosis
Patients with other diseases which result in peripheral neuromuscular dysfunction
In targeted muscles which display pronounced weakness or atrophy

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.